Personalized Stem Cells

Thank you!

Your information is on the way. If it does not arrive in your inbox within the next minute or two, please check your spam folder.

Frequently Asked Questions

  • Physician screens and accepts patient
  • Day #1 – Physician collects fat
  • Day #2 – PSC processes fat and creates doses
  • Day #3 through 18 – Quality testing of cells – quality approval
  • Any time after approval – cells are delivered for injection Extra cells are stored for future use


The cells produced from processing of adipose are commonly referred to as Stromal Vascular Fraction (SVF) cells. The SVFs contains multiple cell types, many of which have been shown to be useful in reduction of inflammation, reduction of pain, and acceleration of healing.


PSC may culture (grow additional cells) cells for potential use in future FDA approved clinical trials. Cultured cells are grown to produce additional doses in order to avoid the need for additional fat collection procedures.


Yes. The PSC cell banking service is designed for long-term stem cell storage. An annual Cell Banking Agreement will be provided after the first year of storage.


PSC supplies stem cells only to physicians treating certain conditions under FDA approved clinical studies. Currently arthritis is being treated. Please see the Clinical Studies page for more information.


PSC plans to apply for FDA IND’sfor additional medical conditions as indicated by the latest clinical evidence and science. Please see the Clinical Studies page for more information. Please contact us with your specific interest so that we can provide updates as available.


Stem Cells:

  • Are the natural healing cells in the body and is derived from a sample of a patient’s own fat
  • Have been shown to
  • Accelerate healing
  • Reduce pain
  • Reduce inflammation
  • Are able to differentiate into multiple cell types


The founders of PSC have more than 20 years of experience conducting clinical studies and operating service laboratories under FDA and USDA guidelines. PSC performs sterility, stability, and purity testing for every process.


Stem cells from fat have 100 to 500 times more stem cells than bone marrow. Also, fat is plentiful and easy to harvest.


Bone marrow:

  • Consists of mostly blood (only 1 out of 50,000 cells is a mesenchymal stem cell)
  • May contain bone fragments, which is not ideal for injecting into joints, tendons, or ligaments
  • Contains variable amounts of growth factors
  • Collection method requires drilling into the bone for harvest


Platelet-rich plasma:

  • PRP has very few stem cells
  • Platelets are harvested from blood and activated before injection
  • Platelets contain growth factors.
  • Unlike Stem Cells, platelets cannot respond to cellular signals, specific tissue needs, or the severity of the injury.


Your physician will review with you the possible risks that are in the Consent Form approved by the Institutional Review Board (IRB) for each clinical trial.


Age may decrease stem cell concentration, but fat almost always contains sufficient cells for doses or culturing of more cells. Your physician includes age as well as other factors while screening for enrollment criteria for each clinical trial.


No. Cells can only be shipped to a physician who is participating in an FDA approved trial sponsored by PSC or to a country that has authorized the use of GMP produced stem cells.


The cells are packaged in sterile vials and shipped to your physician in a cryogenic shipping system.


The cost for participation in each clinical trial will vary depending on the cost for diagnosis, eligibility screening, number and type of treatments, and follow up exams. You should review costs with your physician prior to enrollment in the clinical trial.


Stem cell therapy is not typically covered by insurance. The cost of diagnosis and post-treatment visits or therapy may be covered. You should review coverages with your insurance carrier prior to enrollment in the clinical trial.


Your physician will review your current medications as part of the eligibility screening process.